USE OF NRG4, OR INHIBITORS THEREOF, IN THE TREATMENT OF COLON AND PANCREATIC CANCER

Details for Australian Patent Application No. 2003237367 (hide)

Owner CHIRON CORPORATION

Inventors KAVANAUGH, W., Michael,; SCHLEYER, Siew, C.; JEFFERSON, Anne, B.; ABRAHAM, Judith, A.,

Pub. Number AU-A-2003237367

PCT Number PCT/US03/17563

PCT Pub. Number WO2003/101401

Priority 60/385,659 03.06.02 US

Filing date 3 June 2003

Wipo publication date 19 December 2003

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/385,659 03.06.02 US

12 February 2004 Application Open to Public Inspection

  Published as AU-A-2003237367

17 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003237368-ANGLED SEALING PATTERN FOR RETORT POUCH TO CREATE COLD CORNERS

2003237366-ASSISTED GPS SIGNAL DETECTION AND PROCESSING SYSTEM FOR INDOOR LOCATION DETERMINATION